CEO Arthur Collins

Medtronic Inc. (NYSE: MDT) Revenue: 4.297 billion, up 4 percent from a year earlierNet income: $991 million, a 28 percent increase from a year earlierEarnings per share: 94 cents, a 31 percent increase from a year earlierCash and cash equivalents at the end of the quarter: $1.2 billion “I am pleased with our improved revenue growth this quarter in a dynamic healthcare environment,” said Omar Ishrak, Medtronic chairman and chief executive...  

and devices for vertebral compression fractures and spinal stenosis. Its CardioVascular segment offers coronary and peripheral stents and related delivery systems, endovascular stent graft systems, distal embolic protection systems, perfusion systems ...  

May 25 (Bloomberg) -- Bloomberg's Shannon Pettypiece reports on a catheter made by Medtronic Inc. that is used in an experimental 20-minute procedure to treat hypertension by cauterizing nerves near the kidneys that control blood pressure. (Source: Bloomberg)  

Sales increases have resulted in a 4 percent increase in fiscal fourth quarter revenue for Fridley, Minn.-based Medtronic Inc. The company reported revenue of nearly $4.3 billion in the fourth quarter and nearly $16.2 billion for fiscal year 2012, an increase of 4 percent over $15.5 billion in fiscal year 2011. “Our growth was broad-based across our businesses and geographies, including strong U.S. launches of the Resolute Integrity drug...  

MINNEAPOLIS--(BUSINESS WIRE)--According to study results to be featured in Sunday’s late-breaking clinical trials session at the American Association of Clinical Endocrinologists (AACE) 21st Annual Scientific and Clinical Congress in Philadelphia, the Resolute® drug-eluting stent (DES) from Medtronic, Inc. (NYSE:MDT) yields strong performance in coronary artery disease (CAD) patients both with and without diabetes through two years of follow...  

Business leaders in Minnesota need to take a active role in opposing a proposed amendment banning same-sex marriage, says former Medtronic Inc. CEO Bill George. George, in an opinion piece in the Star Tribune, says that the amendment's passage would make it more difficult for Minnesota's global companies to recruit top-level talent — "not just gays, but anyone whose choice is to be part of an open society that rewards performance over social...  

The U.S. Department of Justice and the Office of the U.S. Attorney for the District of Massachusetts have reportedly closed their investigation of Medtronic Inc. and its Infuse Bone Graft product, failing to find any wrongdoing on the company’s part. The Department of Justice began the investigation in October 2008. Designed in and is distributed out of Memphis, Infuse is a genetically engineered bone protein that stimulates bone growth. It...  

Medtronic Inc. said Wednesday it is laying off 220 people from a Twin Cities facility that makes pacemakers and implantable cardiac defibrillators. The layoffs are occurring at Medtronic's Cardiac Rhythm Management facility in Mounds View. Medtronic spokesman Steve Cragle said the 220 people already had been notified that their positions had been eliminated. He said the move is part of the normal adjusting of staffing levels based on market...  

(RTTNews.com) - Medtronic, Inc. (MDT) posted fourth-quarter net earnings of $991 million or $0.94 per share, higher than last year's $776 million or $0.72 per share. Adjusted earnings per share for the quarter rose to $0.99 from $0.90 a year ...  

May 22 (Reuters) - Medtronic Inc reported higher quarterly earnings on Tuesday as weaker sales in its key markets for implantable heart defibrillators and spinal products were offset by stronger sales in its other divisions. Looking ahead to ...  

Medtronic Inc. (MDT), the world’s biggest maker of heart-rhythm devices, reported fourth-quarter profit that beat analyst estimates and said 2013 earnings will be as much as $3.70 a share. Profit excluding one-time items in the three months ...  

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic (NYSE: MDT) will host an institutional investor and analyst meeting on Friday, June 1, 2012, in New York City from 9:00 a.m. to approximately 1:00 p.m. Eastern Daylight Time. The meeting will include remarks from the Medtronic management team highlighting the company’s strategy for delivering improved growth and creating long-term shareholder value. Medtronic will host a webcast of the meeting to provide...  

MINNEAPOLIS (AP) - Medical device maker Medtronic Inc. said Wednesday that federal prosecutors have closed their investigation of the company's InFuse bone graft. The world's largest medical device company was being investigated by the U.S ...  

Medtronic's earnings surged surged 28 percent higher in its fourth quarter over the same period last year on growth or stabilization across many of its businesses, the company said Tuesday. Minneapolis-based Medtronic posted profits of $991 ...  

Medtronic, the world's largest medical device company, on Tuesday reported fourth quarter net earnings of $991 million, or $0.94 per diluted share -- an increase of 28 percent and 31 percent over the company's fourth quarter of 2011. The Fridley ...